MA26768A1 - Combinaison de chimiotherapie - Google Patents

Combinaison de chimiotherapie

Info

Publication number
MA26768A1
MA26768A1 MA26275A MA26275A MA26768A1 MA 26768 A1 MA26768 A1 MA 26768A1 MA 26275 A MA26275 A MA 26275A MA 26275 A MA26275 A MA 26275A MA 26768 A1 MA26768 A1 MA 26768A1
Authority
MA
Morocco
Prior art keywords
chemotherapy combination
chemotherapy
combination
Prior art date
Application number
MA26275A
Other languages
English (en)
Inventor
Carleton Gowan Richard
Sebolt-Leopold Judith
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MA26768A1 publication Critical patent/MA26768A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA26275A 1998-12-22 2001-07-19 Combinaison de chimiotherapie MA26768A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11329198P 1998-12-22 1998-12-22
US16478899P 1999-11-10 1999-11-10

Publications (1)

Publication Number Publication Date
MA26768A1 true MA26768A1 (fr) 2004-12-20

Family

ID=26810891

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26275A MA26768A1 (fr) 1998-12-22 2001-07-19 Combinaison de chimiotherapie

Country Status (31)

Country Link
EP (1) EP1140291B1 (fr)
JP (1) JP2002532570A (fr)
KR (1) KR20010099877A (fr)
CN (1) CN1333698A (fr)
AP (1) AP2001002175A0 (fr)
AT (1) ATE310567T1 (fr)
AU (1) AU2203900A (fr)
BG (1) BG105715A (fr)
BR (1) BR9916839A (fr)
CA (1) CA2352326A1 (fr)
CZ (1) CZ20012139A3 (fr)
DE (1) DE69928568T2 (fr)
EA (1) EA200100687A1 (fr)
EE (1) EE200100339A (fr)
ES (1) ES2253928T3 (fr)
GE (1) GEP20043172B (fr)
HK (1) HK1042057A1 (fr)
HR (1) HRP20010473A2 (fr)
HU (1) HUP0104844A3 (fr)
ID (1) ID30250A (fr)
IL (1) IL143939A0 (fr)
IS (1) IS5969A (fr)
MA (1) MA26768A1 (fr)
NO (1) NO20013099L (fr)
NZ (1) NZ512859A (fr)
OA (1) OA11733A (fr)
PL (1) PL348326A1 (fr)
SK (1) SK8712001A3 (fr)
TR (1) TR200101871T2 (fr)
WO (1) WO2000037141A1 (fr)
YU (1) YU45401A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006213A2 (fr) * 2000-07-19 2002-01-24 Warner-Lambert Company Esters oxygenes d'acides 4-iodophenylamino benzhydroxamiques
EP1365796A2 (fr) 2000-09-01 2003-12-03 Van Andel Institute Inhibition de la voie de la proteine mapkkk: une strategie therapeutique selective contre les melanomes
EP1377312A4 (fr) * 2001-03-22 2004-10-06 Andel Inst Van Facteur letal de l'anthrax inhibant la croissance tumorale et l'angiogenese
IL149462A0 (en) 2001-05-09 2002-11-10 Warner Lambert Co Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
EP1676837A4 (fr) * 2003-10-08 2008-09-10 Teijin Pharma Ltd Methode de production d'un derive d'aminopyrrolidine et d'un compose intermediaire
BRPI0415710A (pt) 2003-10-21 2006-12-19 Warner Lambert Co formas polimórficas de n-[(r)-2,3-dihidróxi-propóxi]-3,4-diflúor-2-(2-flúor-4-io dofenilamino)-benzamida
AR051248A1 (es) 2004-10-20 2007-01-03 Applied Research Systems Derivados de 3-arilamino piridina
CN1807413B (zh) * 2005-09-28 2010-05-05 中国医学科学院医药生物技术研究所 咔唑磺酰胺衍生物及其制备方法
CN103524392B (zh) 2005-10-07 2018-06-01 埃克塞利希斯股份有限公司 作为用于治疗增生性疾病的mek 抑制剂的吖丁啶
EP1790342A1 (fr) 2005-11-11 2007-05-30 Zentaris GmbH Dérivés de pyridopyrazine et leur utilisation comme modulateurs de transduction de signal
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
AU2006313701B2 (en) 2005-11-11 2012-05-31 Aeterna Zentaris Gmbh Novel pyridopyrazines and their use as modulators of kinases
ES2703723T3 (es) 2006-12-14 2019-03-12 Exelixis Inc Métodos para usar inhibidores de MEK
EP2370568B1 (fr) 2008-12-10 2017-07-19 Dana-Farber Cancer Institute, Inc. Mutations de mek conférant une résistance aux inhibiteurs de mek
EP3028699B1 (fr) 2010-02-25 2018-03-21 Dana-Farber Cancer Institute, Inc. Mutations braf conférant une résistance aux inhibiteurs de braf
EP2545187B1 (fr) 2010-03-09 2018-09-05 Dana-Farber Cancer Institute, Inc. Procédés de diagnostic et de traitement du cancer chez des patients ayant ou développant une résistance à une première thérapie anticancéreuse
CN103301096B (zh) * 2012-03-14 2015-05-06 中国中化股份有限公司 取代二苯胺类化合物作为制备抗肿瘤药物的应用
WO2013169858A1 (fr) 2012-05-08 2013-11-14 The Broad Institute, Inc. Méthodes de diagnostic et de traitement chez des patients ayant ou présentant un risque de développer une résistance à une thérapie anticancéreuse
HRP20180670T1 (hr) 2012-10-12 2018-07-13 Exelixis Inc. Novi postupak dobivanja spojeva namijenjenih upotrebi u liječenju raka
WO2014133071A1 (fr) 2013-02-27 2014-09-04 第一三共株式会社 Procédé de prédiction de la réactivité à un composé inhibant la voie de transduction du signal de mapk
CN105384754B (zh) * 2014-09-02 2018-04-20 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
CN111909053B (zh) * 2020-08-06 2022-12-06 湖北省生物农药工程研究中心 基于二芳胺单元的酰胺类衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112248A0 (en) * 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
WO1997032604A1 (fr) * 1996-03-07 1997-09-12 Novartis Ag Combinaisons antiproliferatives contenant des oligonucleotides cibles sur raf et des composes chimiotherapeutiques
WO1998037881A1 (fr) * 1997-02-28 1998-09-03 Warner Lambert Company Methode de traitement ou de prevention du choc septique par administration d'un inhibiteur mek
JP2001517954A (ja) * 1997-03-21 2001-10-09 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム Ｎｏｅｙ２遺伝子組成物およびその使用方法
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6040321A (en) * 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
US5959097A (en) * 1998-11-20 1999-09-28 Isis Pharmaceuticals, Inc. Antisense modulation of MEK2 expression

Also Published As

Publication number Publication date
EP1140291A1 (fr) 2001-10-10
BR9916839A (pt) 2001-10-09
NO20013099L (no) 2001-08-20
NZ512859A (en) 2004-06-25
PL348326A1 (en) 2002-05-20
NO20013099D0 (no) 2001-06-21
HUP0104844A3 (en) 2003-05-28
OA11733A (en) 2005-05-12
HK1042057A1 (zh) 2002-08-02
HRP20010473A2 (en) 2002-08-31
EP1140291B1 (fr) 2005-11-23
EE200100339A (et) 2002-10-15
DE69928568T2 (de) 2006-07-27
SK8712001A3 (en) 2002-02-05
ES2253928T3 (es) 2006-06-01
KR20010099877A (ko) 2001-11-09
BG105715A (en) 2002-04-30
DE69928568D1 (de) 2005-12-29
AU2203900A (en) 2000-07-12
AP2001002175A0 (en) 2001-06-21
TR200101871T2 (tr) 2001-10-22
IL143939A0 (en) 2002-04-21
GEP20043172B (en) 2004-02-25
HUP0104844A2 (en) 2002-06-29
EA200100687A1 (ru) 2001-12-24
ATE310567T1 (de) 2005-12-15
YU45401A (sh) 2004-07-15
ID30250A (id) 2001-11-15
JP2002532570A (ja) 2002-10-02
WO2000037141A9 (fr) 2000-12-07
CA2352326A1 (fr) 2000-06-29
WO2000037141A1 (fr) 2000-06-29
CZ20012139A3 (cs) 2002-01-16
IS5969A (is) 2001-06-14
CN1333698A (zh) 2002-01-30

Similar Documents

Publication Publication Date Title
NO20005215D0 (no) Dihydropyrimidiner
NO984956D0 (no) Brenner
ID26974A (id) Ketoenol siklik arilfenil-tersubstitusi
ID30250A (id) Kemoterapi kombinasi
FI980536A7 (fi) Kokoonpanolinja
ID21853A (id) Popok pasang sekali pakai
DE69933073D1 (de) Informationsaufzeichnungsträgercassette
IS6571A (is) Samsett lyfjameðferð
ID24221A (id) Tempat patrum
DE69902762D1 (de) Riser-spannanordnung
FR2789651B1 (fr) Combinaison de glisse aquatique
NO20000746L (no) Brenner
ATE262513T1 (de) Benzoylpyridazine
DE69929274D1 (de) Durchflussbegrenzer
ATA179498A (de) Theodolit
DE59808995D1 (de) Endomikroskopsystem
FR2753608B1 (fr) Combinaison de maintien
NO20005325D0 (no) Bjelkelagskonstruksjon
DE59901263D1 (de) Einzelplatz-sortierer
ATA32198A (de) Beschlag
ATA149998A (de) Ladenbeschlag
DE59907164D1 (de) Beschlagteil
FR2787738B1 (fr) Degauchisseuse-raboteuse
FR2769475B3 (fr) Combinaison vestimentaire
FI981252A0 (fi) Tiskipöydän pesuallasjärjestely